About Nuuvera
Nuuvera is an Agriculture company based in Leamington (Canada) founded in 2017, and was acquired by Aphria in January 2018. Cannabis-based medicinal products are produced and distributed by Nuuvera. Nuuvera has raised $2.24 million across 1 funding round from investors including Aphria and Fastforward Innovations. Nuuvera has completed 1 acquisition, including FL Group. Its focus areas include Food and Agriculture Tech, Crop Tech, Indoor Farming and Hydroponics. Its competitors include Organigram, Canopy Growth and Cannara Biotech; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 2017 and based in Leamington, Canada, Nuuvera operates in the cannabis sector. Research and development are conducted through the owned Avanti Rx Analytics laboratory. Extraction and production of new strains occur via proprietary methods, yielding refined extracts that retain terpenes for flavor and medicinal effects. Cannabis is sourced from growers in Italy, Germany, and Israel, with distribution focused on medicinal applications.
- Headquarters Leamington, Canada
- Stage Acquired
- SectorsAgriculture
- Emailβ’β’β’β’β’β’β’β’
- Website nuuvera.com
- Social LinkedIn X
- Acquired by Aphria (Jan 2018)
Funding Insights of Nuuvera
Nuuvera has successfully raised a total of $2.24M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.24 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.24M
- Total Rounds 1
- Last Round Seed β $2.24M
- First Round $2.24M
(Mar 2017)
- Investors Count 1
All 1 funding rounds of Nuuvera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $2.24M | Seed | β | β |
2 investors in total: 2 institutional.
Investors in Nuuvera
Nuuvera has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Aphria and Fastforward Innovations.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & life Science focused early stage VC firm investing in North America & Europe | 2006 | fstfwd.co | Saint Peter Port, Guernsey | |
Cannabis-derived nutritional and wellness products are provided by Aphria. | 2014 | aphria.ca | Leamington, Canada |
Investor details for Nuuvera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nuuvera
Nuuvera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include FL Group.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cannabis raw materials services are provided by FL Group. | fl-group.it | Vado Ligure, Italy | 2013 | Jan 2018 | β’β’β’β’ |
Complete acquisition details for Nuuvera
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Nuuvera
Nuuvera has 3 listed competitors in our database, 1 of them funded. They include Organigram, Canopy Growth and Cannara Biotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| organigram.ca | 2013 | Moncton, Canada | Provider of cannabis products, brands, and international business development investments | |||
| canopygrowth.com | 2013 | Smiths Falls, Canada | 170 | Cannabis products are provided to support consumer wellness and health. | ||
| cannara.ca | 2018 | Montreal, Canada | $17.66M | Medicinal cannabis cultivation facility |
Detailed competitors of Nuuvera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nuuvera
Complete news archive for Nuuvera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nuuvera
Nuuvera was founded in 2017.
Nuuvera is headquartered in Leamington, Canada. It is registered at Leamington, Ontario, Canada.
Nuuvera is a funded company, having raised a total of $2.24M across 1 funding round to date. The company's 1st funding round was a Seed of $2.24M, raised on Mar 2017.
Founded in 2017 and based in Leamington, Canada, Nuuvera operates in the cannabis sector. Research and development are conducted through the owned Avanti Rx Analytics laboratory. Extraction and production of new strains occur via proprietary methods, yielding refined extracts that retain terpenes for flavor and medicinal effects. Cannabis is sourced from growers in Italy, Germany, and Israel, with distribution focused on medicinal applications.
Nuuvera's top competitors include Canopy Growth, Organigram and Cannara Biotech.
Nuuvera has made 1 acquisition, including FL Group.
Nuuvera has 2 investors. Key investors include Aphria, and Fastforward Innovations.
Yes. Nuuvera was acquired by Aphria in January 2018.

